REFERENCES
- Freund T F, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Am Physiol Soc 2003; 83: 1017–1066
- Matsuda L A, Lolait S J, Brownstein M J, et al. Structure of cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561–564, [INFOTRIEVE], [CSA], [CROSSREF]
- Munro S, Thomas K L, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365: 61–64, [INFOTRIEVE], [CSA], [CROSSREF]
- Herkenham M, Lynn A B, Little M D, et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 1990; 87: 1932–1936, [INFOTRIEVE], [CSA], [CROSSREF]
- Mailleux P, Vanderhaeghen J J. Distribution of neuronal cannabinoid receptor in the adult rat brain; A comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 1992; 48: 655–668, [INFOTRIEVE], [CSA], [CROSSREF]
- Westlake T M, Howlett A C, Bonner T I, et al. Cannabinoid receptor binding and messenger RNA expression in human brain: An in vivo receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience 1994; 63: 637–652, [INFOTRIEVE], [CSA], [CROSSREF]
- Glass M, Faull R LM, Dragunow M. Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study on fetal neonatal and adult human brain. Neuroscience 1997; 77: 299–318, [INFOTRIEVE], [CSA], [CROSSREF]
- Galiegue S, Mary S, Marchand J, et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995; 232: 54–61, [INFOTRIEVE], [CSA], [CROSSREF]
- Ishac E J, Jiang L, Lake K D, et al. Inhibition of exocytic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br J Pharmacol 1996; 118: 2023–2028, [INFOTRIEVE], [CSA]
- Ameri A. Effects of cannabinoids on the brain. Prog Neurobiol 1999; 58: 315–348, [INFOTRIEVE], [CSA], [CROSSREF]
- Howlett A C, Barthe F, Bonner T I, et al. International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002; 54: 161–202, [INFOTRIEVE], [CSA], [CROSSREF]
- Jarvinen T, Pate D W, Laine K. Cannabinoids in the treatment of glaucoma. Pharmacol Ther 2002; 95: 203–220, [INFOTRIEVE], [CSA], [CROSSREF]
- Straiker A, Stella N, Piomelli D, et al. Cannabinoid CB1 receptors and ligands in vertebrae localization and function of an endogenous signaling system. Proc Natl Acad Sci USA 1999; 96: 14565–14570, [INFOTRIEVE], [CSA], [CROSSREF]
- Yazulla S, Studholme K M, McIntosh H H, Fan S H. Cannabinoid receptors on goldfish retinal bipolar cells: electron-microscope immunocytochemistry and whole cell recordings. Vis Neurosci 2000; 17: 391–401, [INFOTRIEVE], [CSA], [CROSSREF]
- Straiker A, Maguire G, Mackie K, Lindsey J. Localization of the cannabinoid CB1 receptors in human anterior eye and retina. Invest Ophthalmol Vis Sci 1999; 20: 2442–2488, [CSA]
- Lu Q, Straiker A, Lu G, Maguire G. Expression of CB2 receptor mRNA in adult rat retina. Vis Neurosci 2000; 17: 91–95, [INFOTRIEVE], [CSA], [CROSSREF]
- Yazulla S, Studholme K M, McIntosh H H, Deutsch D G. Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina. J Comp Neurol 1999; 415: 80–90, [INFOTRIEVE], [CSA], [CROSSREF]
- Sharif N A. Multiple synaptic receptors for neuroactive amino acid transmitters—new vistas. Int Rev Neurobiol 1985; 26: 85–150, [INFOTRIEVE], [CSA]
- Massey S C. Cell types using glutamate as a neurotransmitter in the vertebrate retina. Prog Retinal Res. 1990; 399–425, [CSA], [CROSSREF]
- Osborne N N, Ugarte M, Chao M, et al. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol. 1999; 43(6)S102–S128, [INFOTRIEVE], [CSA], [CROSSREF]
- Marc R E. The role of glycine in the mammalian retina. Prog Retinal Res. 1988; 9: 67–107, [CSA], [CROSSREF]
- Benveniste H, Drejer J, Schousboe A, Diemer N M. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 1984; 43: 1369–1374, [INFOTRIEVE], [CSA]
- Lu Y, Lu B F, Zhao F Q, et al. Accumulation of glutamate is regulated by calcium and protein kinase C in rat hippocampal slices exposed to ischemic states. Hippocampus 1993; 3: 221–227, [INFOTRIEVE], [CSA], [CROSSREF]
- Virgili M, Contestabile A, Barnabei O. Simultaneous blockade of non-NMDA ionotropic receptors and NMDA receptor-associated ionophore partially protects hippocampal slices from protein synthesis impairment due to simulated ischemia. Hippocampus. 1995; 5(1)91–97, [INFOTRIEVE], [CSA], [CROSSREF]
- Novelli A, Reilly J A, Lysko P G, Henneberry R C. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 1988; 451: 205–212, [INFOTRIEVE], [CSA], [CROSSREF]
- Cox J A, Lysko P G, Henneberry R C. Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: Role of the voltage-dependent magnesium block. Brain Res 1989; 499: 267–272, [INFOTRIEVE], [CSA], [CROSSREF]
- Choi D W. Excitotoxic cell death. J Neurobiol. 1992; 23: 1261–1276, [INFOTRIEVE], [CSA], [CROSSREF]
- Shen M, Thayer S A. Δ−9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture. Mol Pharmacol 1998; 55(1)8–13, [CSA]
- Yoles E, Belkin M, Schwartz M. HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy. J Neurotrauma. 1996; 13(1)49–57, [INFOTRIEVE], [CSA]
- Lopez-Colome A, Somohano F. Effect of selective kainate lesions on the release of glutamate and aspartate from check retina. J Neurosci Res 1986; 15: 205–216, [INFOTRIEVE], [CSA], [CROSSREF]
- Santos P F, Duarte C B, Carvalho A P. Glutamate receptor agonists evoked Ca(2 +)–dependent and Ca(2 +) independent release of [3H]D-aspartame from cultured chick retina cells. Neurochem Res 1996; 21: 361–368, [INFOTRIEVE], [CSA]
- Storm-Mathisen J. Autoradiographic and microchemical localization of high affinity glutamate uptake. Glutamate: Transmitter in the Central Nervous System, P Roberts, J Storm-Mathisen, C Johnston. John Wiley & Sons, New York 1981; 89–115
- Ohia S E, Opere C A, Awe S O, et al. Human, bovine and rabbit retinal glutamate-induced [3H] D-aspartate release: Role in excitotoxicity. Neurochem Res 2000; 25: 853–860, [INFOTRIEVE], [CSA], [CROSSREF]
- Ohia S E, Awe S O, Opere C A, et al. Hypoxia-induced [3H] D-aspartate release from isolated bovine retina: Modulation by calcium-channel blockers and glutamatergic agonists and antagonists. Curr Eye Res. 2001; 23(5)386–392, [INFOTRIEVE], [CSA], [CROSSREF]
- Ohia S E, Awe S O, Opere C A, et al. Glucose-deprivation-induced [3H] D-aspartate release from isolated bovine and human retinae. J Ocular Pharmacol Ther 2003; 19: 599–609, [CSA], [CROSSREF]
- Zablocka B, Domanska-Janik K. Enhancement of 3[H]D-aspartate release during ischemia like conditions in rat hippocampal slices: Source of excitatory amino acids. Acta Neurobiol Exp (Wars) 1996; 56(1)63–70, [CSA]
- Rego A C, Santos M S, Oliveira C R. Oxidative stress, hypoxia, and ischemia-like conditions increase the release of endogenous amino acids by distinct mechanisms in cultured retinal cells. J Neurochem. 1996; 66(6)2506–2516, [INFOTRIEVE], [CSA]
- Schlicker E, Timm J, Gothert M. Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn Schmiedebergs Arch Pharmacol 1996; 354: 791–795, [INFOTRIEVE], [CSA], [CROSSREF]
- Devanes W A, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992; 258(5090)1946–1949, [CSA]
- Sugiura T, Waku K. 2-Arachidonoylglycerol and the cannabinoid receptors. Chem Phys Lipids. 2000; 108(1-2)89–106, [INFOTRIEVE], [CSA], [CROSSREF]
- Fride E, Foox A, Rosenbergc E, et al. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: Evidence for a “CB3” receptor. Eur Pharmacol. 2003; 461(1)27–34, [CSA], [CROSSREF]
- Zygmunt P M, Petersson J, Andersson D A, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 1999; 400(6743)452–457, [INFOTRIEVE], [CSA], [CROSSREF]
- Van der Stelt M, Di Marzo V. Anandamide as an intracellular messenger regulating ion channel activity. Prostaglandins Other Lipid Mediat. 2005; 77(1-4)111–122, [INFOTRIEVE], [CSA], [CROSSREF]
- Di Marzo V, Fontana A, Cadas H, et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994; 372: 686–691, [INFOTRIEVE], [CSA], [CROSSREF]
- Hillard C J, Manna S, Greenberg M J, et al. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Ther. 1999; 289(3)1427–1433, [INFOTRIEVE], [CSA]
- Abadji V, Lin S, Taha G, et al. (R)-Methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J Med Chem 1994; 37: 1889–1893, [INFOTRIEVE], [CSA], [CROSSREF]
- Breivogel C S, Walker J M, Huang S M, et al. Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids. Neuropharmacology. 2004; 47(1)81–91, [INFOTRIEVE], [CSA], [CROSSREF]
- Kofalvi A, Vizi E S, Ledent C, Sperlagh B. Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action. Eur J Neurosc. 2003; 18(7)1973–1978, [CSA], [CROSSREF]
- Wang S J. Cannabinoid CB1 receptor-mediated inhibition of glutamate release from rat hippocampal synaptosomes. Eur J Pharmacol. 2003; 469(1-3)47–55, [INFOTRIEVE], [CSA], [CROSSREF]
- Gong J P, Onaivi E S, Ishiguro H, et al. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 2006; 1071(1)10–23, Epub 2006 Feb 9[INFOTRIEVE], [CSA], [CROSSREF]
- Small-Howard A L, Shimoda L M, Adra C N, Turner H. Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells. Biochem J. 2005; 388(Pt 2)465–473, [INFOTRIEVE], [CSA]
- Sterin-Borda L, Del Zar C F, Borda E. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: Endogenous signal transduction pathways. Biochem Pharmacol 2005; 69(12)1705–1713, [INFOTRIEVE], [CSA]
- Huffman J W. CB2 receptor ligands. Mini Rev Med Chem 2005; 5(7)641–649, [INFOTRIEVE], [CSA]
- Zhong L, Geng L, Njie Y, et al. CB2 cannabinoid receptors in trabecular meshwork cells mediate JWH015-induced enhancement of aqueous humor outflow facility. Invest Ophthalmol Vis Sci 2005; 46(6)1988–1992, [INFOTRIEVE], [CSA], [CROSSREF]
- Bonz A, Kaser M, Kullmer S, et al. Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle. J Cardiovasc Pharmacol 2003; 41(4)657–664, [INFOTRIEVE], [CSA], [CROSSREF]
- Mukherji S, Adams M, Whiteaker K, et al. Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors. Eur J Pharmacol. 2004; 505(1-3)1–9, [CSA], [CROSSREF]
- Lan R, Gatley J, Lu Q, et al. Design and synthesis of the CB1 selective cannabinoid antagonist AM281: A potential human SPECT ligand. AAPS Pharm Sci. 1999; 1(2)E4, [CSA], [CROSSREF]
- Kreitzer A C, Carter A G, Regehr W G. Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum. Neuron. 2002; 34(5)787–796, [INFOTRIEVE], [CSA], [CROSSREF]
- Trettel J, Levine E S. Cannabinoids depress inhibitory synaptic inputs received by layer 2/3 pyramidal neurons of the neocortex. J Neurophysiol. 2002; 88(1)534–539, [INFOTRIEVE], [CSA]
- Kreitzer A C, Regehr W G. Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J Neurosci. 2001; 21(20)RC174, [INFOTRIEVE], [CSA]
- Wagner J A, Abesser M, Karcher J, et al. Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts. J Cardiovasc Pharmacol. 2005; 46(3)348–355, [INFOTRIEVE], [CSA], [CROSSREF]
- Ford W R, Honan S A, White R, Hiley C R. Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts. Br J Pharmacol 2002; 135(5)1191–1198, [INFOTRIEVE], [CSA], [CROSSREF]
- Hajos N, Ledent C, Freund T F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 2001; 106(1)1–4, [INFOTRIEVE], [CSA], [CROSSREF]
- Shen M, Piser T, Seybold V, Thayer S. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 1996; 16: 4322–4334, [INFOTRIEVE], [CSA]
- Levenes C, Daniel H, Soubrie P, Crepel F. Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells. J Physiol. 1998; 510(Pt 3)867–879, [INFOTRIEVE], [CSA], [CROSSREF]
- Werner N A, Koch J E. Effects of the cannabinoid antagonists AM281 and AM630 on deprivation-induced intake in Lewis rats. Brain Res. 2003; 967(1–2)290–292, [INFOTRIEVE], [CSA], [CROSSREF]
- Sinor A D, Irvin S M, Greenberg D A. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci Lett 2000; 278: 157–160, [INFOTRIEVE], [CSA], [CROSSREF]
- Dreyer E B, Surakowski D, Schumer R A, et al. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 1996; 114(3)299–305, [INFOTRIEVE], [CSA]
- Carter-Dawson L, Crawford M L, Harwerth R S, et al. Vitreal glutamate concentration in monkeys with experimental glaucoma. Invest Ophthalmol Vis Sci 2002; 43(8)2633–2637, [INFOTRIEVE], [CSA]
- Tomida I, Pertwee R G, Azuara-Blanco A. Cannabinoids and glaucoma. Br J Ophthalmol 2004; 88(5)708–713, [INFOTRIEVE], [CSA], [CROSSREF]